• Contact us about your case
  • Plaquemine Office:
    Phone: 888-725-2477
  • Fax: (225) 687-6398
  • New Orleans Office:
    Phone: (504) 355-0086
  • Fax: (504) 523-0699

Fosamax Femur Fracture

May 16th, 2011

Long-term use of the drug Fosamax, a Bisphosphonate, may increase the risk of low-energy bone fractures, involving the thigh bone or femur.  A study published in The Journal of American Medical Association on February 23, 2011, concludes that prolonged Bisphosphonate use leads to devastating femur fractures.  Normally a large amount of force is required to break this bone.  Ironically, Fosamax is designed to prevent bone loss and reduce the risk of broken bones. Fosamax is prescribed to treat osteoporosis and reduce... Read More

Posted in Current Cases, firm-news |

Birth Defects and Their Connection to Antidepressant & Anti-Anxiety Drugs

May 9th, 2011

For the past decade numerous scientific studies have shown that use of SSRIs during pregnancy significantly increases the risk of serious side effects, including miscarriage and severe birth defects.  Such SSRI birth defects include Persistent Pulmonary Hypertension in the Newborn (PPHN), serious heart defects, and other congenital abnormalities. Despite the overwhelming evidence about these SSRI side effects, these drugs remain on the market and are heavily prescribed to treat conditions like depression, anxiety, and other mental health conditions.  While the... Read More

Posted in Current Cases, firm-news |

Defective 6.0L Power Stroke Diesel Engine Leads To Class Action Lawsuit Against Ford Motor Company and Navistar, Inc.

May 8th, 2011

Pendley, Baudin & Coffin, L.L.P. Files Class Action Lawsuit Against Ford Motor Company and Navistar, Inc.  East Baton Rouge Parish, Louisiana, March 29, 2011 – East Baton Rouge Parish resident Rena Brown and West Baton Rouge resident Kem Anderson filed a lawsuit today on behalf of a class of Louisiana consumers against Ford Motor Company and Navistar, Inc. (f/k/a International Truck and Engine Corporation) in the United States District Court for the Middle District of Louisiana. The class action lawsuit... Read More

Posted in Current Cases, firm-news |

GAF Timberline Shingles

May 6th, 2011

A class action lawsuit has been filed on behalf of consumers of GAF Timberline shingles.  The lawsuit alleges that the GAF 30 to 40 year shingles are failing within 4 to 6 years of installation.  Consequently, the lawsuit claims, homeowners with GAF Timberline shingles are forced to replace their roof prematurely. If you have GAF Timberline shingles that have experienced failure as stated above, contact the attorneys at Pendley, Baudin and Coffin, L.L.P. to have your potential case evaluated. Read More

Posted in Current Cases |

Whistleblower (Qui Tam) Lawsuits

May 2nd, 2011

The lawyers at Pendley, Baudin & Coffin, L.L.P., are experienced in handling whistleblower lawsuits.  Currently, the firm is involved in the prosecution of two whistleblower actions:  (1) An environmental contamination and failure to pay royalties case against a major U.S. oil company.  (2) A pharmaceutical off-label promotion case against an international pharmaceutical manufacturer. If you would like to speak to one of the lawyers at Pendley, Baudin & Coffin, L.L.P. about a potential whistleblower lawsuit, contact us by filling out... Read More

Posted in Current Cases |

Breast Implants Linked To Rare Cancer

January 26th, 2011

The FDA announced a possible link between saline and silicone gel-filled breast implants and a rare type of cancer known as anaplastic large cell lymphoma (ALCL).  The FDA reported on its website that the cancer targets the immune system and is found in the scar capsule adjacent to the implant.  The cases that the FDA reviewed were diagnosed in patients whose symptoms such as pain, lumps, swelling or asymmetry that developed after their surgical sites were fully healed, sought treatment. ... Read More

Posted in Current Cases, firm-news |

Antidepressants Linked To Birth Defects

January 20th, 2011

Antidepressants including Celexa, Effexor, Lexapro, Paxil and Zoloft have been linked to an increased risk of birth defects.   Antidepressants (SSRIs [selective serotonin reuptake inhibitors]), such as Celexa (citalopram), Effexor (venlaxafine), Lexapro (escitalopram), Paxil (paroxetine) and Zoloft (sertraline), since September of 2005 have been suspected to cause birth defects including: Heart (cardiac) Lung (pulmonary) Brain and spinal cord (neural-tube defects) Abnormally shaped skull (craniosynostosis) Abdominal wall defects (infant omphalocele) Club foot (one or both feet turn downward and inward) Complete or... Read More

Posted in Current Cases, firm-news |

DePuy Orthopedics Recalls Its ASR XL Acetabular Hip Replacement And Resurfacing System

January 4th, 2011

Due to a high rate of revision surgeries to correct or remove defective implants, DePuy Orthopedics has recalled its ASR XL acetabular hip replacement and resurfacing system.  These revision surgeries are painful and expensive and recovery often takes as long as the initial hip surgery. DePuy was alleged to have known that the cup had design problems, but did not warn physicians.  In a letter to doctors in March of 2010, DePuy warned of a “higher than expected” failure rate... Read More

Posted in Current Cases, firm-news |

Federal Judge Denies Drug Manufacturers’ Motion to Dismiss Consumers’ Class Action Claims in Celexa/Lexapro Litigation

November 15th, 2010

Working on behalf of consumers who purchased Celexa or Lexapro for their children, lawyers at Pendley, Baudin & Coffin, L.L.P. and Korein Tillery were successful in defeating a motion to dismiss filed by Forest Laboratories, Inc. and Forest Pharmaceuticals, Inc. in Massachusetts federal court. The federal judge presiding over the case, Judge Nathaniel Gorton, ruled that any decisions related to dismissal of the Celexa and Lexapro consumers’ claims are better left for determination at the class certification stage of the... Read More

Posted in Current Cases, firm-news |

Knauf Plasterboard Agrees To Partial Settlement Of Chinese Drywall Litigation

October 14th, 2010

The Chinese Drywall Legal Network announces that a settlement has been reached with Knauf Plasterboard (Tianjin) Co., Ltd. (“KPT”) in the national Chinese drywall litigation pending in New Orleans. In an effort to eventually resolve all of the lawsuits arising from drywall manufactured and exported to the United States by KPT, KPT has agreed to remediate up to 300 homes.  This remediation “pilot program” is expected to serve as a model for a possible future global remediation program. Homes eligible... Read More

Posted in Current Cases, firm-news |

© 2012 Pendley, Baudin & Coffin, L.L.P. All rights reserved.